Different patterns of activation markers expression and CD4+T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS)

被引:16
作者
Kosmaczewska, A.
Bilinska, M.
Ciszak, L.
Noga, L.
Pawlak, E.
Szteblich, A.
Podemski, R.
Frydecka, I.
机构
[1] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Expt Therapy, Immunopathol Lab, PL-53114 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Neurol, PL-50420 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Hematol, PL-50420 Wroclaw, Poland
[4] Wroclaw Med Univ, Dept Pathophysiol, PL-50420 Wroclaw, Poland
关键词
multiple sclerosis; remission; CTLA-4; IFN-gamma; activated CD4+T cells; sCTLA-4;
D O I
10.1016/j.jneuroim.2007.06.021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients with relapsing-remitting (RR) and secondary progressive (SP) forms of multiple sclerosis (MS), although in long-term clinical remission, showed different patterns of increased expressions of the activation markers: CD69, CD40L, and both membrane/surface and cytoplasmic CTLA-4 (mCTLA-4 and cCTLA-4, respectively) in freshly isolated peripheral blood (PB) CD4+ T cells compared with controls. Also observed were dysregulated responses to ex vivo stimulation in both groups of MS patients accompanied by increased IFN-gamma synthesis. Our findings may suggest that the mechanisms leading to each clinical form of the disease may be heterogeneous. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 146
页数:10
相关论文
共 64 条
[1]   ELEVATED SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN PATIENTS WITH ACTIVE MULTIPLE-SCLEROSIS [J].
ADACHI, K ;
KUMAMOTO, T ;
ARAKI, S .
ANNALS OF NEUROLOGY, 1990, 28 (05) :687-691
[2]   CD28-B7 INTERACTIONS IN T-CELL ACTIVATION [J].
ALLISON, JP .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :414-419
[3]  
ANTEL JP, 1986, J IMMUNOL, V137, P136
[4]  
Bartik MM, 1998, SEMIN ONCOL, V25, P27
[5]   CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression [J].
Carreno, BM ;
Bennett, F ;
Chau, TA ;
Ling, V ;
Luxenberg, D ;
Jussif, J ;
Baroja, ML ;
Madrenas, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1352-1356
[6]  
CASTLE BE, 1993, J IMMUNOL, V151, P1777
[7]   ISOLATION AND CHARACTERIZATION OF AUTOREACTIVE PROTEOLIPID PROTEIN-PEPTIDE SPECIFIC T-CELL CLONES FROM MULTIPLE-SCLEROSIS PATIENTS [J].
CORREALE, J ;
MCMILLAN, M ;
MCCARTHY, K ;
LE, T ;
WEINER, LP .
NEUROLOGY, 1995, 45 (07) :1370-1378
[8]   REACTIVITY TO MYELIN ANTIGENS IN MULTIPLE-SCLEROSIS - PERIPHERAL-BLOOD LYMPHOCYTES RESPOND PREDOMINANTLY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN [J].
DEROSBO, NK ;
MILO, R ;
LEES, MB ;
BURGER, D ;
BERNARD, CCA ;
BENNUN, A .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2602-2608
[9]   DEMONSTRATION OF CYTOPLASMIC AND NUCLEAR ANTIGENS IN ACUTE-LEUKEMIA USING FLOW-CYTOMETRY [J].
FARAHAT, N ;
VANDERPLAS, D ;
PRAXEDES, M ;
MORILLA, R ;
MATUTES, E ;
CATOVSKY, D .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (09) :843-849
[10]   Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis [J].
Filion, LG ;
Matusevicius, D ;
Graziani-Bowering, GM ;
Kumar, A ;
Freedman, MS .
CLINICAL IMMUNOLOGY, 2003, 106 (02) :127-+